Latest News and Press Releases

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hub Group (HUBG) To Contact Him Directly To Discuss Their Options If you purchased or...

SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth...

Midland, Texas, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Natural Gas Services Group, Inc. (NYSE: NGS), (“NGS” or the “Company”), a leading provider of natural gas compression equipment, technology, and...

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Graphite One Inc. (TSX‐V: GPH; OTCQX: GPHOF)...

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended December 31, 2025....

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Alvotech...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PomDoctor (POM) To Contact Him Directly To Discuss Their Options If you purchased or...

Robbins LLP is investigating claims that Ultragenyx (RARE) misled investors about Phase III Orbit and Cosmic trials for setrusumab.

Agomab Therapeutics NV today announced the closing of its previously announced initial public offering of 12,500,000 American Depositary Shares (“ADSs”)

Company to Appoint Two New Independent Directors and Form Transformation Committee Focused on Operational Excellence and Margin Improvement Company Enters into Cooperation Agreement with Engine...